Connecticut 2022 Regular Session Status: Enacted Bipartisan · 18 D · 14 R cosponsors

HB 5430 — AN ACT CONCERNING OPIOIDS.

Last action — SIGNED BY GOVERNOR

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced March 09, 2022. Enacted.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 78% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 45 sponsors

    45 primary, 0 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (18 D · 14 R) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Bill Text

What changed in the latest version

245 added · 427 removed

245 line(s) added, 427 removed.

→
Previous
Latest
House of Representatives File No.
Substitute House Bill No.
582 General Assembly February Session, 2022Reprint of File No.
5430 Public Act No.
416) Substitute House Bill No.
22-108 AN ACT CONCERNING OPIOIDS.
5430 As Amended by House Amendment Schedule "B" Approved by the Legislative Commissioner April 21, 2022 AN ACT CONCERNING OPIOIDS.
The treatment agreement or care plan shall, at a minimum, include treatment goals, risks of using opioids, urine drug screens and expectations regarding the continuing treatment of pain with opioids, such as situations requiring discontinuation of opioid treatment and, to the extent possible, nonopioid treatment options, including, but not limited to manipulation, chiropractic, spinal cord stimulation, massage therapy, acupuncture, physical therapy and other treatment regimens or sHB5430 / File No.
The treatment agreement or care plan shall, at a minimum, include treatment goals, risks of using opioids, urine drug screens and expectations regarding the continuing treatment of pain with opioids, such as situations requiring discontinuation of opioid treatment and, to the extent possible, nonopioid treatment options, including, but not limited to manipulation, chiropractic, spinal cord stimulation, massage therapy, acupuncture, physical therapy and other treatment regimens or modalities.
582 sHB5430 File No.
582 modalities.
Subdivision (20) of section 21a-240 of the 2022 supplement to the general statutes is repealed and the following is substituted in lieu thereof (Effective July 1, 2022):
Subdivision (20) of section 21a-240 of the 2022 supplement to the general statutes is repealed and the following is substituted in lieu Substitute House Bill No.
5430 thereof (Effective July 1, 2022):
(ix) objects used, intended for use or designed for use in ingesting, inhaling, or otherwise introducing marijuana, cocaine, hashish, or hashish oil into the human sHB5430 / File No.
(ix) objects used, intended for use or designed for use in ingesting, inhaling, or otherwise introducing marijuana, cocaine, hashish, or hashish oil into the human body, [such as:
582 sHB5430 File No.
Metal] including, but not limited to, wooden, acrylic, glass, stone, plastic or ceramic pipes with screens, permanent screens, Public Act No.
582 body, [such as:
22-108 2 of 9 Substitute House Bill No.
Metal] including, but not limited to, wooden, acrylic, glass, stone, plastic or ceramic pipes with screens, permanent screens, hashish heads or punctured metal bowls;
5430 hashish heads or punctured metal bowls;
Every practitioner who distributes, administers or dispenses any controlled substance or who proposes to engage in distributing, prescribing, administering or dispensing any controlled substance within this state shall (1) obtain a certificate of registration issued by the Commissioner of Consumer Protection in accordance with the provisions of this chapter, [and] (2) if the practitioner is engaged in sHB5430 / File No.
Every practitioner who distributes, administers or dispenses any controlled substance or who proposes to engage in distributing, prescribing, administering or dispensing any controlled substance within this state shall (1) obtain a certificate of registration issued by the Commissioner of Consumer Protection in accordance with the provisions of this chapter, [and] (2) if the practitioner is engaged in Public Act No.
582 sHB5430 File No.
22-108 3 of 9 Substitute House Bill No.
582 prescribing a controlled substance, register for access to the electronic prescription drug monitoring program established pursuant to subsection(j)ofsection21a-254[.Registrationforaccesstosaidprogram shall be in a manner prescribed by said commissioner] in a manner prescribed by the commissioner, and (3) if the practitioner is engaged in transporting a controlled substance for the purpose of treating a patient in a location that is different than the address that the practitioner provided to the Department of Consumer Protection as a registrant, as defined in section 21a-240, as amended by this act, notify the department, in a manner prescribed by the commissioner, of the intent to transport such controlled substance and, after dispensing such controlled substance, return any remaining amount of such controlled substance to a secure location at the address provided to the department.
5430 prescribing a controlled substance, register for access to the electronic prescription drug monitoring program established pursuant to subsection(j)ofsection21a-254[.Registrationforaccesstosaidprogram shall be in a manner prescribed by said commissioner] in a manner prescribed by the commissioner, and (3) if the practitioner is engaged in transporting a controlled substance for the purpose of treating a patient in a location that is different than the address that the practitioner provided to the Department of Consumer Protection as a registrant, as defined in section 21a-240, as amended by this act, notify the department, in a manner prescribed by the commissioner, of the intent to transport such controlled substance and, after dispensing such controlled substance, return any remaining amount of such controlled substance to a secure location at the address provided to the department.
Such behavioral health services or substance use disorder treatment services may include methadone delivery and related substance use treatment services to persons in a nursing home facility pursuant to the provisions of section sHB5430 / File No.
Such behavioral health Public Act No.
582 sHB5430 File No.
22-108 4 of 9 Substitute House Bill No.
582 19a-495corinamobile narcotictreatmentprogram,asdefinedin21 CFR 1300.
5430 services or substance use disorder treatment services may include methadone delivery and related substance use treatment services to persons in a nursing home facility pursuant to the provisions of section 19a-495corinamobile narcotictreatmentprogram,asdefinedin21 CFR 1300.
(D) an appropriate array of prevention, treatment and recovery services along with a sustained continuum of care;
(D) an appropriate array of prevention, treatment Public Act No.
22-108 5 of 9 Substitute House Bill No.
5430 and recovery services along with a sustained continuum of care;
(G) department sHB5430 / File No.
(G) department policies and guidelines concerning recovery-oriented care;
582 sHB5430 File No.
582 policies and guidelines concerning recovery-oriented care;
Subsection (c) of section 17a-710 of the general statutes is repealed and the following is substituted in lieu thereof (Effective from passage):
Subsection (c) of section 17a-710 of the general statutes is Public Act No.
22-108 6 of 9 Substitute House Bill No.
5430 repealed and the following is substituted in lieu thereof (Effective from passage):
Such programs shall be developed in collaboration with other state sHB5430 / File No.
Such programs shall be developed in collaboration with other state agencies providing child care, family support, health services and early interventionservicesforparentsandyoungchildren.Suchcollaboration shall not be limited to agencies providing substance [abuse] use disorder services.
582 sHB5430 File No.
582 agencies providing child care, family support, health services and early interventionservicesforparentsandyoungchildren.Suchcollaboration shall not be limited to agencies providing substance [abuse] use disorder services.
and (4) "Peer navigator" means a person who (A) has experience working with persons with substance use disorder, as defined in section 20-74, (B) provides nonmedical mental health care and substance use services to such persons, and (C) has a collaborative relationship with a health care professionalauthorizedto prescribe medicationsto treat opioiduse disorder.
and (4) "Peer navigator" means a person who (A) has experience working with persons with substance use disorder, as defined in section 20-74, (B) provides nonmedical mental health care and substance use services to such persons, and (C) has a collaborative relationship with a health care professionalauthorizedto prescribe medicationsto treat opioiduse Public Act No.
22-108 7 of 9 Substitute House Bill No.
5430 disorder.
The team shall work in the community to (1) increase sHB5430 / File No.
The team shall work in the community to (1) increase engagement between providers of treatment services, health care and social services and persons with opioid use disorder, (2) improve the retention of such persons in treatment for opioid use disorder by addressing social determinants of health of such persons and emerging local conditions that affect such social determinants of health, and (3) increase the capacity of the community to support such persons by identifying and addressing systemic barriers to treatment services, health care, social services and social support of such persons.
582 sHB5430 File No.
582 engagement between providers of treatment services, health care and social services and persons with opioid use disorder, (2) improve the retention of such persons in treatment for opioid use disorder by addressing social determinants of health of such persons and emerging local conditions that affect such social determinants of health, and (3) increase the capacity of the community to support such persons by identifying and addressing systemic barriers to treatment services, health care, social services and social support of such persons.
(d)OnorbeforeJanuary1,[2023]2024,thecommissionershallreport, in accordance with the provisions of section 11-4a, to the joint standing committee of the General Assembly having cognizance of matters relating to public health regarding the success of the pilot program in serving persons with opioid use disorder and any recommendations for continuing the pilot program or expanding the pilot program into other communities in the state.
(d)OnorbeforeJanuary1,[2023]2024,thecommissionershallreport, in accordance with the provisions of section 11-4a, to the joint standing committee of the General Assembly having cognizance of matters relating to public health regarding the success of the pilot program in serving persons with opioid use disorder and any recommendations for continuing the pilot program or expanding the pilot program into other Public Act No.
This act shall take effect as follows and shall amend the following sections:
22-108 8 of 9 Substitute House Bill No.
Section 1 July 1, 2022 20-14s Sec.
5430 communities in the state.
Show all 111 changed rows (71 more)
Previous
Latest
2 July 1, 2022 21a-240(20) Sec.
Approved May 24, 2022 Public Act No.
3 July 1, 2022 21a-317 Sec.
22-108 9 of 9
4 July 1, 2022 19a-493(c)(1) Sec.
5 July 1, 2022 17a-451(j) Sec.
6 from passage 17a-710(c) Sec.
7 from passage 17a-673b sHB5430 / File No.
582 sHB5430 File No.
582 The following Fiscal Impact Statement and Bill Analysis are prepared for the benefit of the members of the General Assembly, solely for purposes of information, summarization and explanation and do not represent the intent of the General Assembly or either chamber thereof for any purpose.
In general, fiscal impacts are based upon a variety of informational sources, including the analyst’s professional knowledge.
Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.
OFA Fiscal Note State Impact:
None Municipal Impact:
None Explanation The bill, which makes various changes regarding opioid use prevention and treatment, has no fiscal impact.
House "B" delays, by one year, the date by which the Department of Mental Health and Addiction Services (DMHAS) must establish a pilot program within available appropriations and report to the Public Health Committee, which has no fiscal impact.
The Out Years State Impact:
None Municipal Impact:
None sHB5430 / File No.
582 9 sHB5430 File No.
582 OLR Bill Analysis sHB 5430 (as amended by House “B”)* AN ACT CONCERNING OPIOIDS.
SUMMARY This bill makes various changes affecting opioid use prevention and treatment.
Specifically, it:
1.
adds chiropractic and spinal cord stimulation to the list of nonopioid treatment options that must be included on a patient’s treatment agreement or care plan that prescribing practitioners must provide when prescribing opioids for more than 12 weeks (§ 1);
2.
removes from the statutory definition of “drug paraphernalia” products used by licensed drug manufacturers or individuals to test a substance before they ingest, inject, or inhale it, (e.g., fentanyl testing strips), as long as they are not using the products to engage in unlicensed manufacturing or distribution of controlled substances (§ 2);
3.
allows practitioners authorized to prescribe controlled substances to treat patients by dispensing controlled substances (e.g., methadone) from a mobile unit (§ 3);
4.
allows multi-care institutions to provide behavioral health services or substance use disorder treatment services in a mobile narcotic treatment program (§ 4);
5.
requirestheDepartmentofMentalHealthandAdditionServices’ (DMHAS) triennial state substance use disorder plan to include department policies, guidelines, and practices to reduce the negative personal and public health impacts of behavior sHB5430 / File No.
582 10 sHB5430 File No.
582 associated with alcohol and drug abuse, including opioid drug abuse (§§ 5 & 6);
and 6.
extends by one year, until January 1, 2023, the date by which DMHAS must establish a pilot program in up to five urban, suburban, and rural communities to serve individuals with opioid use disorder (§ 7).
The bill also makes technical and conforming changes.
*House Amendment “B” extends the date by which DMHAS must establish a pilot program to serve individuals with opioid use disorder.
EFFECTIVE DATE:
July 1, 2022, except that the provisions making technical changes to the state substance use disorder plan (§ 6) and extending the date by which DMHAS must establish a pilot program on opioid use disorder take effect upon passage (§ 7).
§ 1 — PRESCRIPTION OPIOID PATIENT CARE PLAN By law, a prescribing practitioner who prescribes more than a 12- week supply ofanopioiddrug to treat apatient’spainmust (1)establish a treatment agreement with the patient or (2) discuss a care plan for the chronic use of opioid drugs with the patient.
Among other things, the agreement or plan must include, to the extent possible, nonopioid treatment options.
The bill adds chiropractic and spinal cord stimulation to these treatment options.
Current law already requires the agreement or plan to include manipulation, massage therapy, acupuncture, physical therapy, and other treatment regimens or modalities.
§ 3 — MOBILE UNITS FOR DISPENSING CONTROLLED SUBSTANCES The bill allows practitioners authorized to prescribe controlled substances to treat patients by dispensing controlled substances (e.g., methadone) through a mobile unit.
Specifically, it requires a prescribing practitioner who transports controlledsubstancestotreatpatientsatadifferentlocationthantheone sHB5430 / File No.
582 11 sHB5430 File No.
582 the practitioner provided the Department of Consumer Protection (DCP) (when obtaining a controlled substances registration and prescription drug monitoring program access), to:
1.
notify DCP, in a manner the commissioner prescribes, of the intent to transport the controlled substances;
2.
after dispensing the controlled substances, return any remaining amount to a secure location at the address provided to DCP;
and 3.
report to the Prescription Drug Monitoring Program any dispensing ofthese substancesthat occursat alocationotherthan the location provided to DCP.
Under the bill, if the practitioner is unable to return any remaining amount of the controlled substances to the address, the commissioner may approve an alternate location, provided it is also approved by the federal Drug Enforcement Agency.
§ 4 — MULTICARE INSTITUTIONS The bill allows multicare institutions to provide behavioral health services or substance use disorder treatment services to patients in a mobile narcotic treatment program (see BACKGROUND).
Existing law authorizes the institutions to provide these services at a satellite unit or other off-site location, so long as they provide the Department of Public Health a list of these locations on their initial or licensure renewal application.
By law, multicare institutions include hospitals, psychiatric outpatient clinics for adults, free-standing facilities for substance abuse treatment, psychiatric hospitals, or general acute care hospitals that provide outpatient behavioral health services that (1) have more than onefacilityoroneormoresatelliteunitsownedandoperatedbyasingle licensee and (2) offer complex patient health care services at each facility or satellite unit.
§ 7 — DMHAS OPIOID USE DISORDER PILOT PROGRAM sHB5430 / File No.
582 12 sHB5430 File No.
582 Existing law requires DMHAS to establish a pilot program, within available appropriations, in up to five urban, suburban, and rural communities to serve individuals with opioid use disorder.
The bill extends, by one year until January 1, 2023, the date by which DMHAS must establish the program.
The bill correspondingly extends by one year, until January 1, 2024, the date by which the DMHAS commissioner must report to the Public Health Committee on the pilot program, including its success and any recommendations to continue or expand it.
Under existing law, each community participating in the pilot program must form a team of at least two peer navigators (see BACKGROUND) who must, among other things, (1) travel throughout the community to address the health care and social needs of individuals with opioid use disorder and (2) be trained on non-coercive and non-stigmatizing ways to engage these individuals, as determined by the DMHAS commissioner.
BACKGROUND Mobile Narcotic Treatment Program Under federalregulation,amobilenarcotictreatment program(NTP) is one that operates from a motor vehicle and serves as a mobile component of a registered NTP.
It provides maintenance or detoxification treatment with Schedules II-IV controlled substances at a location remote from, but within the same state as, the registered NTP (21 C.F.R.
§ 1300).
Peer Navigator By law, a “peer navigator” is a person with experience working with individuals with substance use disorder who (1) provides nonmedical mentalhealth care and substance use services and(2) hasa collaborative relationship with health care professionals authorized to prescribe medications to treat opioid use disorder.
COMMITTEE ACTION sHB5430 / File No.
582 13 sHB5430 File No.
582 Public Health Committee Joint Favorable Substitute Yea 28 Nay 1 (03/25/2022) sHB5430 / File No.
582 14
⬇ Download PDF
View plain text versions (5)

Action History

  1. SIGNED BY GOVERNOR

  2. TRANSMITTED BY SECRETARY OF THE STATE TO GOVERNOR

  3. TRANSMITTED TO SECRETARY OF THE STATE

  4. PUBLIC ACT 22-108

  5. IN CONCURRENCE

  6. SEN. PASSED, HO. AMEND. SCH. B

  7. SEN. ADOPTED HO. AMEND. SCH. B

  8. FILE NO. 582

  9. SENATE CALENDAR NUMBER 414

  10. FAV. RPT., TAB. FOR CAL., SEN.

  11. HOUSE PASSED, HOUSE AMEND. SCH. B

  12. HOUSE ADOPTED HOUSE AMEND. SCH. B

  13. HOUSE REJECTED HOUSE AMEND. SCH. A

  14. FILE NO. 416

  15. HOUSE CALENDAR NUMBER 295

  16. FAV. RPT., TABLED FOR HOUSE CALENDAR

  17. RPTD. OUT OF LCO

  18. REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 04/11/22

  19. FILED WITH LCO

  20. Joint Favorable Substitute

  21. PUBLIC HEARING 0314

  22. REF. TO JOINT COMM. ON Public Health

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

45 sponsors · 0 co-sponsors · 142 not signed on

Sponsors (45)

Co-sponsors (0)

None.

Not signed on (142)

142 members have not signed on to this bill.

Show all 142 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare labor
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 5430?
HB 5430 is sponsored by Joe Polletta (Republican), Rebimbas, Rosa C., Eric C. Berthel (Republican), Irene M. Haines (Republican), David Rutigliano (Republican), Fiorello, Kimberly, Geraldo C. Reyes (Democratic), Josh Elliott (Democratic), Kenneth Gucker (Democratic), Lucy Dathan (Democratic), Hampton, John K., Kara Rochelle (Democratic), Jason Rojas (Democratic), Witkos, Kevin D., Matt Blumenthal (Democratic), Dave W. Yaccarino (Republican), Heather S. Somers (Republican), Palm, Christine, Tami Zawistowski (Republican), Eleni Kavros DeGraw (Democratic), Bill Buckbee (Republican), Joseph H. Zullo (Republican), John A. Kissel (Republican), Tom O'Dea (Republican), John-Michael Parker (Democratic), Formica, Paul M., Carol Hall (Republican), Anne M. Hughes (Democratic), Anthony L. Nolan (Democratic), Paul Cicarella (Republican), Aimee Berger-Girvalo (Democratic), Fazio, Ryan, Arora, Harry, Raghib Allie-Brennan (Democratic), Cook, Michelle L., Saud Anwar (Democratic), Cheeseman, Holly H., Michael DiGiovancarlo (Democratic), Conley, Christine, Jillian Gilchrest (Democratic), Williams, Quentin, Stephen G. Harding (Republican), Hubert D. Delany (Democratic), Cristin McCarthy Vahey (Democratic), and Mccarty, K..
What is the current status of HB 5430?
This bill has been enacted into law. Introduced March 09, 2022. Enacted.
Where can I track HB 5430?
Track HB 5430 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 5430

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 5430

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →